Home > Result Summaries: Compounds > ropinirole > Result Summary for 101468/188

Result Summary for 101468/188

Result Summary

Protocol ID:	101468/188
Clinical Study ID:	SKF-101468/188
Official Title:	A Study of the Maintained Efficacy and Safety of Ropinirole Versus Placebo in the Long Term Treatment of Restless Legs Syndrome (RLS)
Phase:	Phase 3
Study Indications or Diseases:	Restless Legs Syndrome
Generic Name:	ropinirole
Trade/Product Name:	requip;requip
Approved Drug Label:	http://www.gsk.com/products.html
Results Summary:	Click here to download result summary.
Citations:	Haan J, Volc D, Montplaisir J. The long-term management of RLS with ropinirole: maintained efficacy over 36 weeks. International Congress of Parkinson’s Disease and Movement Disorders, Rome, Italy, Jun 13–17 2004. Mov Disord 2004; 19(suppl 9): S420: P1232 Montplaisir, J 1; Karrasch, J 2; Haan, J 3; Kruger, AJ 4, and Volc, D 5, 2681061 (1) Sleep Disorders Clinic, Hopital du Sacre-Coeur de Montreal, Montreal, QC, Canada; 2) Peninsula Clinical Research Centre, Kipparing, QLD, Australia; 3) Kliniken Maria Hilf GmbH, Neurologische Klinik, Schlafmedizinisches Zentrum, Moenchengladbach, Germany; 4) Neurology Department, University of The Free State, Bloemfontein, Free State, South Africa; 5) Confraternitaet - Privatklinik, Josefstadt, Wien, Austria). The Impact of Ropinirole Treatment on RLS Symptoms and Health-Related Quality of Life (HRQoL) in Patients with RLS: Results of a Multinational 36-Week Study [656]. 6/5/2004: 1) Sleep Disorders Clinic, Hopital du Sacre-Coeur de Montreal Montreal QC Canada; 2) Peninsula Clinical Research Centre, Kipparing QLD Australia; 3) Kliniken Maria Hilf GmbH, Neurologische Klinik Schlafmedizinisches Zentrum Moenchengladbach Germany; 4) Neurology Department, University of The Free State Bloemfontein Free State Montplaisir, Jacques 1; Karrasch, Jeff 2; Haan, Jean 3; Kruger, Abraham J. 4, and Volc, Dieter 5, 2556012 (1) Montreal, QC, Canada; 2) Kipparing, Australia; 3) Moenchengladbach, Germany; 4) Bloemfontein, South Africa; 5) Vienna, Austria). The Impact of Ropinirole Treatment on Health-Related Quality of Life (HRQoL) in Patients with RLS: Results of a Multinational 36-Week Study [P01.080]. 4/24/2004: 1) Montreal, QC Canada; 2) Kipparing, Australia; 3) Moenchengladbach, Germany; 4) Bloemfontein, South Africa, and 5) Vienna, Austria, 5/1/2004. 56th Annual Meeting of the American Academy of Neurology; San Francisco, CA; USA. San Francisco, CA; USA; 2004 Apr 24; c2004.